Next, the regulatory effect of hnRNPL on CCL2 expression was examined with ELISA and qRT-PCR assays, which showed that CCL2 expression was decreased in hnRNPL-silenced bladder cancer cells (Fig. 6g, h; Supplementary Fig. 9b, c). This evidence concerns the gene CCL2 and urinary bladder carcinoma.